Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$446,652
+$9,024 QoQ
Shares Held
2,850
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#940
of 1,603 holders
Holding Since
Dec 2021
19 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WULFF, HANSEN & CO. holds $6,552,139 across 6 Drug Manufacturers - General names. NVS ranks #5 (6.8% of the industry book) .
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,652 | 2,850 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $437,628 | 2,865 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $394,997 | 2,865 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $375,102 | 2,925 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $353,954 | 2,925 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $326,636 | 2,930 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $286,577 | 2,945 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $350,235 | 3,045 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $324,170 | 3,045 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $295,026 | 3,050 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $322,599 | 3,195 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $325,442 | 3,195 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $297,179 | 2,945 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $270,940 | 2,945 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $310,716 | 3,425 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $260,334 | 3,425 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $289,515 | 3,425 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $300,543 | 3,425 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $364,749 | 4,170 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||